Hauser RA - Search Results

1

Clinical presentation and pharmacological therapy in corticobasal degeneration.

Kompoliti K, Goetz CG, Boeve BF, Maraganore DM, Ahlskog JE, Marsden CD, Bhatia KP, Greene PE, Przedborski S, Seal EC, Burns RS, Hauser RA, Gauger LL, Factor SA, Molho ES, Riley DE. Kompoliti K, et al. Among authors: hauser ra. Arch Neurol. 1998 Jul;55(7):957-61. doi: 10.1001/archneur.55.7.957. Arch Neurol. 1998. PMID: 9678313 Clinical Trial.

2

The effect of deprenyl and levodopa on the progression of Parkinson's disease.

Olanow CW, Hauser RA, Gauger L, Malapira T, Koller W, Hubble J, Bushenbark K, Lilienfeld D, Esterlitz J. Olanow CW, et al. Among authors: hauser ra. Ann Neurol. 1995 Nov;38(5):771-7. doi: 10.1002/ana.410380512. Ann Neurol. 1995. PMID: 7486869 Clinical Trial.

3

The effect of L-dopa infusions with and without phenylalanine challenges in parkinsonian patients: plasma and ventricular CSF L-dopa levels and clinical responses.

Woodward WR, Olanow CW, Beckner RM, Hauser RA, Gauger LL, Cedarbaum JM, Nutt JG. Woodward WR, et al. Among authors: hauser ra. Neurology. 1993 Sep;43(9):1704-8. doi: 10.1212/wnl.43.9.1704. Neurology. 1993. PMID: 8414016

4

A pilot evaluation of the tolerability, safety, and efficacy of tolcapone alone and in combination with oral selegiline in untreated Parkinson's disease patients. Tolcapone De Novo Study Group.

Hauser RA, Molho E, Shale H, Pedder S, Dorflinger EE. Hauser RA, et al. Mov Disord. 1998 Jul;13(4):643-7. doi: 10.1002/mds.870130406. Mov Disord. 1998. PMID: 9686768 Clinical Trial.

5

Randomized, placebo-controlled study of tolcapone in patients with fluctuating Parkinson disease treated with levodopa-carbidopa. Tolcapone Fluctuator Study Group III.

Adler CH, Singer C, O'Brien C, Hauser RA, Lew MF, Marek KL, Dorflinger E, Pedder S, Deptula D, Yoo K. Adler CH, et al. Among authors: hauser ra. Arch Neurol. 1998 Aug;55(8):1089-95. doi: 10.1001/archneur.55.8.1089. Arch Neurol. 1998. PMID: 9708959 Clinical Trial.

6

Ropinirole for the treatment of early Parkinson disease: a 12-month experience. Ropinirole Study Group.

Sethi KD, O'Brien CF, Hammerstad JP, Adler CH, Davis TL, Taylor RL, Sanchez-Ramos J, Bertoni JM, Hauser RA. Sethi KD, et al. Among authors: hauser ra. Arch Neurol. 1998 Sep;55(9):1211-6. doi: 10.1001/archneur.55.9.1211. Arch Neurol. 1998. PMID: 9740115 Clinical Trial.

7

Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease.

Hauser RA, Freeman TB, Snow BJ, Nauert M, Gauger L, Kordower JH, Olanow CW. Hauser RA, et al. Arch Neurol. 1999 Feb;56(2):179-87. doi: 10.1001/archneur.56.2.179. Arch Neurol. 1999. PMID: 10025423

8

Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease.

Freeman TB, Vawter DE, Leaverton PE, Godbold JH, Hauser RA, Goetz CG, Olanow CW. Freeman TB, et al. Among authors: hauser ra. N Engl J Med. 1999 Sep 23;341(13):988-92. doi: 10.1056/NEJM199909233411311. N Engl J Med. 1999. PMID: 10498497 No abstract available.

9

A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia.

Hauser RA, Friedlander J, Zesiewicz TA, Adler CH, Seeberger LC, O'Brien CF, Molho ES, Factor SA. Hauser RA, et al. Clin Neuropharmacol. 2000 Mar-Apr;23(2):75-81. doi: 10.1097/00002826-200003000-00003. Clin Neuropharmacol. 2000. PMID: 10803796 Clinical Trial.

10

Pramipexole-induced somnolence and episodes of daytime sleep.

Hauser RA, Gauger L, Anderson WM, Zesiewicz TA. Hauser RA, et al. Mov Disord. 2000 Jul;15(4):658-63. doi: 10.1002/1531-8257(200007)15:4<658::aid-mds1009>3.0.co;2-n. Mov Disord. 2000. PMID: 10928575 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

339 results

Search Page

Filters